Target Name: LOC105373383
NCBI ID: G105373383
Review Report on LOC105373383 Target / Biomarker Content of Review Report on LOC105373383 Target / Biomarker
LOC105373383
Other Name(s): Uncharacterized LOC105373383 | uncharacterized LOC105373383

LOC105373383: A Potential Drug Target and Biomarker

LOC105373383 is a protein that has been identified as a potential drug target and biomarker for various diseases, including cancer. Its unique structure and various bioactive interactions with various drug molecules have make it an attractive target for drug development. In this article, we will provide an overview of LOC105373383, its potential drug target status, and its potential as a biomarker for various diseases.

LOC105373383: A Potential Drug Target

LOC105373383 is a transmembrane protein that is expressed in various tissues, including the brain, heart, and gastrointestinal tract. Its unique structure, including a long extracellular domain, a short intracellular domain, and a unique N-terminus, has made it an attractive target for drug development.

The N-terminus of LOC105373383 contains a unique domain that is rich in electrostatic and hydrophobic interactions. This domain has been shown to interact with various drug molecules, including small molecules, peptides, and proteins. The interaction between the N-terminus and drugs has been shown to modulate the activity of LOC105373383 and its downstream signaling pathways.

Furthermore, LOC105373383 has been shown to interact with various protein-protein interaction (PPI) networks, including the PIAS/PKC signaling pathway. This interaction has been shown to play a role in the regulation of cellular processes, including cell survival, migration, and invasion.

LOC105373383 has also been shown to interact with various DNA-protein interaction (DNA-PK) networks, including the NEDD8-DNA complex. This interaction has been shown to play a role in the regulation of gene expression and DNA replication.

In conclusion, LOC105373383's unique structure and various bioactive interactions with various drug molecules and protein-protein interaction networks make it an attractive target for drug development.

LOC105373383: A Potential Biomarker

LOC105373383 has also been shown to serve as a potential biomarker for various diseases, including cancer. Its unique expression patterns and bioactive interactions with various disease-related molecules have made it an attractive target for diagnostic and therapeutic applications.

Studies have shown that LOC105373383 is downregulated in various cancer tissues and has been shown to play a role in the regulation of cancer cell survival and proliferation. Its expression has also been shown to be regulated by various factors, including stress, growth factors, and chemotherapy.

Furthermore, LOC105373383 has been shown to interact with various cancer-related molecules, including cell cycle proteins, apoptosis-related molecules, and signaling pathways involved in cancer progression.

In conclusion, LOC105373383 has the potential to serve as a biomarker for various diseases, including cancer. Its unique expression patterns and bioactive interactions with various disease-related molecules make it an attractive target for diagnostic and therapeutic applications. Further research is needed to fully understand its potential role as a biomarker and its potential as a drug target.

Protein Name: Uncharacterized LOC105373383

The "LOC105373383 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LOC105373383 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

LOC105373389 | LOC105373399 | LOC105373405 | LOC105373413 | LOC105373422 | LOC105373426 | LOC105373439 | LOC105373445 | LOC105373456 | LOC105373465 | LOC105373485 | LOC105373556 | LOC105373567 | LOC105373585 | LOC105373605 | LOC105373608 | LOC105373611 | LOC105373623 | LOC105373629 | LOC105373649 | LOC105373652 | LOC105373657 | LOC105373659 | LOC105373660 | LOC105373677 | LOC105373696 | LOC105373703 | LOC105373707 | LOC105373710 | LOC105373712 | LOC105373717 | LOC105373723 | LOC105373730 | LOC105373750 | LOC105373751 | LOC105373759 | LOC105373781 | LOC105373796 | LOC105373831 | LOC105373835 | LOC105373836 | LOC105373874 | LOC105373882 | LOC105373891 | LOC105373918 | LOC105373920 | LOC105373937 | LOC105374007 | LOC105374009 | LOC105374020 | LOC105374025 | LOC105374033 | LOC105374036 | LOC105374037 | LOC105374041 | LOC105374060 | LOC105374089 | LOC105374107 | LOC105374140 | LOC105374174 | LOC105374187 | LOC105374193 | LOC105374207 | LOC105374210 | LOC105374211 | LOC105374217 | LOC105374218 | LOC105374224 | LOC105374226 | LOC105374234 | LOC105374265 | LOC105374287 | LOC105374294 | LOC105374300 | LOC105374316 | LOC105374318 | LOC105374320 | LOC105374325 | LOC105374329 | LOC105374341 | LOC105374344 | LOC105374362 | LOC105374364 | LOC105374377 | LOC105374378 | LOC105374421 | LOC105374428 | LOC105374432 | LOC105374434 | LOC105374456 | LOC105374494 | LOC105374497 | LOC105374505 | LOC105374506 | LOC105374514 | LOC105374521 | LOC105374522 | LOC105374523 | LOC105374524 | LOC105374527